With the popularization of assisted reproductive technology, more and more families are turning their attention to Kyrgyzstan.

Not only are laws and regulations perfect here, but its reproductive medical technology is also becoming increasingly mature.

For families seeking assisted reproductive services, reducing the miscarriage rate and ensuring a healthy birth of the fetus are core concerns.

The Tulip International Reproductive Center effectively addresses this challenge by introducing an international standard medical monitoring system and a scientific embryo transfer strategy.

Below, we will delve into how assisted reproduction in Kyrgyzstan achieves high pregnancy rates and low risk of miscarriage.

Q1: How does pre pregnancy medical screening lay the foundation for successful pregnancy?

In Kyrgyzstan, assisted reproduction is a rigorous medical process. The first step in reducing the miscarriage rate begins with strict medical screening of caring mothers who help conceive.

The Tulip International Reproductive Center implements a high standard admission mechanism in this aspect:

Basic health and reproductive system assessment: The doctor will conduct a comprehensive physical examination of the candidate, including blood pressure, blood sugar, liver and kidney functions, etc., to exclude hypertension, diabetes and other basic diseases that may lead to complications during pregnancy. At the same time, by examining the morphology of the uterus and ovarian function through transvaginal ultrasound, factors that may affect embryo implantation such as uterine fibroids, endometrial polyps, or polycystic ovary syndrome can be ruled out.

Hormone level detection: Detect indicators such as AMH (anti Mullerian hormone), FSH (follicle stimulating hormone), LH (luteinizing hormone), and E2 (estradiol). These data not only reflect ovarian reserve, but also indirectly confirm whether the hormone secretion axis is stable, which is crucial for maintaining subsequent pregnancies.

Infectious disease screening: strictly screen hepatitis B, hepatitis C, syphilis, AIDS and other infectious diseases to ensure the purity and safety of the maternal environment.

Only candidates who meet medical standards in all indicators can enter the assisted reproductive talent pool of Tulip International Reproductive Center, reducing the risk of miscarriage caused by maternal health issues from the source.

Q2: How to reduce miscarriage caused by chromosomal abnormalities through embryo laboratory techniques?

Scientific research has shown that the main cause of early natural miscarriage often stems from chromosomal abnormalities in the embryo itself. Therefore, the quality of the "seed" directly determines the outcome of pregnancy.

Embryo culture technology: The developmental potential of traditional cleavage stage embryos (day 3) is still unclear. The Tulip International Reproductive Center typically cultures fertilized eggs in a laboratory environment until the blastocyst stage of 5-7 days. The blastocyst structure is more stable, with a larger number of cells, and is better able to adapt to the physiological environment inside the uterine cavity. Its implantation rate is significantly higher than that of early embryos.

PGT (Preimplantation Genetic Testing): This is a key technology for reducing miscarriage rates. Through PGT-A technology, embryologists can perform biopsies on the trophoblast cells of blastocysts to analyze whether their chromosome number and structure are normal (non diploid screening). This can effectively eliminate embryos carrying chromosomal abnormalities such as trisomy 21 syndrome. Transplanting "diploid" embryos that have undergone genetic screening can significantly reduce the risk of miscarriage and biochemical pregnancy caused by genetic issues.

Q3: What are the unique features of Kyrgyzstan's embryo transfer strategy?

Having a healthy embryo and a healthy mother, the timing and strategy of transplantation are equally crucial. The Tulip International Reproductive Center adopts personalized transplantation programs to improve success rates.

Endometrial receptivity regulation: Prior to transplantation, doctors will use estrogen and progesterone drugs to prepare the endometrium of expectant mothers to achieve the desired thickness range (usually 8mm-12mm) and present a "three line sign" suitable for implantation. Doctors will use ultrasound monitoring to accurately locate the 'implantation window', which is the brief time window during which the endometrium is most likely to receive embryos.

Single blastocyst transfer (eSET) strategy: In order to ensure maternal and infant safety, modern medicine is increasingly promoting single blastocyst transfer. Multiple pregnancies significantly increase the risk of premature birth, miscarriage, gestational hypertension, and fetal development restriction. By transplanting a high-quality blastocyst that has undergone PGT screening, it can ensure a high success rate of pregnancy and effectively avoid obstetric complications caused by multiple pregnancies, thereby indirectly reducing the miscarriage rate.

Q4: How to protect fetal development through immune regulation and monitoring after transplantation?

After embryo implantation, the maternal immune system response and hormone support are key to maintaining pregnancy.

Immune and thrombotic risk management: Some recurrent miscarriages may be related to immune rejection or pre thrombotic status. Doctors will use low molecular weight heparin or low-dose aspirin as necessary based on the examination results to improve uterine microcirculation, prevent microthrombus formation, and ensure sufficient blood supply to the placenta. For cases with the risk of immune rejection, corresponding immunosuppressive strategies will be developed.

Dynamic monitoring of HCG and progesterone: After transplantation, the medical team at Tulip International Reproductive Center closely tracks the doubling of HCG (human chorionic gonadotropin) and progesterone levels in the blood. The good growth of HCG is a barometer of embryonic development vitality, while sufficient progesterone is a necessary condition for maintaining uterine rest and preventing miscarriage.

Real case sharing: Scientific assisted reproduction helps elderly couples achieve their dreams

Case background: Ms. W (41 years old) and her husband have experienced three natural abortions (miscarriage) in China due to chromosomal abnormalities. They, exhausted both physically and mentally, ultimately decided to seek help in Kyrgyzstan, a country with friendly policies and reliable medical technology, and chose the Tulip International Reproductive Center.

Treatment process:

Promotion and screening: The doctor developed a micro stimulation promotion plan based on Ms. W's ovarian function, resulting in the retrieval of 8 eggs and the formation of 4 blastocysts.

Key Technology Application (PGT-A): Perform PGT-A screening on these 4 blastocysts. The results showed that three of them had chromosomal aneuploidy abnormalities (which was the fundamental reason for Ms. L's previous repeated miscarriages), and only one was a completely healthy diploid blastocyst.

Preparation for Assisted Pregnancy Mothers: The center matched them with a caring mother who is 26 years old, has had a natural childbirth experience, and has excellent physical indicators. The doctor adjusted the thickness of the endometrium to 9.5mm and increased blood flow through medication.

Precise transplantation and fetal preservation: Implant the precious healthy blastocyst during the endometrial window period. After transplantation, the doctor administered sufficient luteal support medication and aspirin to improve blood supply based on the hormone levels of the assisting mother.

On the 12th day of transplantation, the HCG value in the blood test was ideal. Ultrasound at 6 weeks of pregnancy shows fetal heartbeat. Throughout the pregnancy, with the remote guidance of the medical team at Tulip International Reproductive Center and the cooperation of local prenatal examination doctors, all indicators of the pregnant mother were stable. In the end, Ms. W and her husband successfully brought back a healthy baby boy in Kyrgyzstan.

The success of the case lies in the elimination of chromosomal abnormalities that cause miscarriage through PGT technology, and the provision of a high-quality breeding environment through the screening of healthy assisted reproductive mothers and scientific luteal support. This is a typical manifestation of medical methods to reduce the miscarriage rate.

For fertility consultation in Kyrgyzstan, please contact your dedicated consultant

/Fertility Consultation /

Dr.Chan

Copy and add: Tulip_EnoChan

Or long press/scan the QR code to add

Tulip International Fertility Center

Technology aids fertility, fulfilling dreams for countless families